ロード中...
Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations
BACKGROUND: Placebo-controlled clinical trials have demonstrated the efficacy of tocilizumab (TCZ) for remission maintenance and glucocorticoid sparing in patients with giant cell arteritis (GCA). However, limited data exist on the effectiveness and safety of TCZ for GCA in real-world clinical pract...
保存先:
| 出版年: | Arthritis Res Ther |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7789742/ https://ncbi.nlm.nih.gov/pubmed/33407817 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-020-02377-8 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|